Vittobai Rashika Rangaraj1, Kristen L Knutson2. 1. Department of Medicine, University of Chicago, Chicago, IL, USA. 2. Department of Medicine, University of Chicago, Chicago, IL, USA. Electronic address: kknutson@medicine.bsd.uchicago.edu.
Abstract
BACKGROUND: Cardiometabolic diseases, which include obesity, diabetes, hypertension, and cardiovascular disease, are associated with reduced quality of life and reduced life expectancy. Unfortunately, there are racial/ethnic and socioeconomic disparities associated with these diseases such that minority populations, such as African Americans and Hispanics, and those of lower socioeconomic status, experience a greater burden. Several reports have indicated that there are differences in sleep duration and quality that mirror the disparities in cardiometabolic disease. The goal of this paper is to review the association between sleep and cardiometabolic disease risk because of the possibility that suboptimal sleep may partially mediate the cardiometabolic disease disparities. METHODS: We review both experimental studies that have restricted sleep duration or impaired sleep quality and examined biomarkers of cardiometabolic disease risk, including glucose metabolism and insulin sensitivity, appetite regulation and food intake, and immune function. We also review observational studies that have examined the association between habitual sleep duration and quality, and the prevalence or risk of obesity, diabetes, hypertension, and cardiovascular disease. CONCLUSION: Many experimental and observational studies do support an association between suboptimal sleep and increased cardiometabolic disease risk.
BACKGROUND:Cardiometabolic diseases, which include obesity, diabetes, hypertension, and cardiovascular disease, are associated with reduced quality of life and reduced life expectancy. Unfortunately, there are racial/ethnic and socioeconomic disparities associated with these diseases such that minority populations, such as African Americans and Hispanics, and those of lower socioeconomic status, experience a greater burden. Several reports have indicated that there are differences in sleep duration and quality that mirror the disparities in cardiometabolic disease. The goal of this paper is to review the association between sleep and cardiometabolic disease risk because of the possibility that suboptimal sleep may partially mediate the cardiometabolic disease disparities. METHODS: We review both experimental studies that have restricted sleep duration or impaired sleep quality and examined biomarkers of cardiometabolic disease risk, including glucose metabolism and insulin sensitivity, appetite regulation and food intake, and immune function. We also review observational studies that have examined the association between habitual sleep duration and quality, and the prevalence or risk of obesity, diabetes, hypertension, and cardiovascular disease. CONCLUSION: Many experimental and observational studies do support an association between suboptimal sleep and increased cardiometabolic disease risk.
Authors: A N Vgontzas; S Pejovic; E Zoumakis; H M Lin; E O Bixler; M Basta; J Fang; A Sarrigiannidis; G P Chrousos Journal: Am J Physiol Endocrinol Metab Date: 2006-08-29 Impact factor: 4.310
Authors: P Heiser; B Dickhaus; W Schreiber; H W Clement; C Hasse; J Hennig; H Remschmidt; J C Krieg; W Wesemann; C Opper Journal: Eur Arch Psychiatry Clin Neurosci Date: 2000 Impact factor: 5.270
Authors: Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal Journal: JAMA Date: 2006-04-05 Impact factor: 56.272
Authors: Marie-Pierre St-Onge; Andrew McReynolds; Zalak B Trivedi; Amy L Roberts; Melissa Sy; Joy Hirsch Journal: Am J Clin Nutr Date: 2012-02-22 Impact factor: 7.045
Authors: Josiane L Broussard; David A Ehrmann; Eve Van Cauter; Esra Tasali; Matthew J Brady Journal: Ann Intern Med Date: 2012-10-16 Impact factor: 25.391
Authors: Slobodanka Pejovic; Maria Basta; Alexandros N Vgontzas; Ilia Kritikou; Michele L Shaffer; Marina Tsaoussoglou; David Stiffler; Zacharias Stefanakis; Edward O Bixler; George P Chrousos Journal: Am J Physiol Endocrinol Metab Date: 2013-08-13 Impact factor: 4.310
Authors: Dale Elizabeth Rae; Lara Ruth Dugas; Laura Catherine Roden; Estelle Vicki Lambert; Pascal Bovet; Jacob Plange-Rhule; Terrence Forrester; Walter Riesen; Wolfgang Korte; Stephanie J Crowley; Sirimon Reutrakul; Amy Luke Journal: Sleep Health Date: 2020-04-19
Authors: Tomás Cabeza de Baca; Koharu Loulou Chayama; Susan Redline; Natalie Slopen; Fumika Matsushita; Aric A Prather; David R Williams; Julie E Buring; Alan M Zaslavsky; Michelle A Albert Journal: Sleep Date: 2019-10-09 Impact factor: 5.849
Authors: P E Brockmann; F Damiani; D L Smith; A Castet; F Nuñez; L Villarroel; D Gozal Journal: Int J Obes (Lond) Date: 2016-08-01 Impact factor: 5.095
Authors: Tao Liang; Heather M Munro; Margaret K Hargreaves; Mark D Steinwandel; William J Blot; Maciej S Buchowski Journal: Sleep Med Date: 2020-09-10 Impact factor: 3.492
Authors: Kelly M Ness; Stephen M Strayer; Nicole G Nahmod; Margeaux M Schade; Anne-Marie Chang; Gregory C Shearer; Orfeu M Buxton Journal: J Lipid Res Date: 2019-09-04 Impact factor: 5.922
Authors: Dayna A Johnson; Guido Simonelli; Kari Moore; Martha Billings; Mahasin S Mujahid; Michael Rueschman; Ichiro Kawachi; Susan Redline; Ana V Diez Roux; Sanjay R Patel Journal: Sleep Date: 2017-01-01 Impact factor: 5.849
Authors: Cormac Powell; Leonard D Browne; Brian P Carson; Kieran P Dowd; Ivan J Perry; Patricia M Kearney; Janas M Harrington; Alan E Donnelly Journal: Sports Med Date: 2020-01 Impact factor: 11.136
Authors: Kelly A Wagner; Ethan Braun; Seth M Armah; Diarmuid Horan; Lisa G Smith; Julie Pike; Wanzhu Tu; Marc T Hamilton; Edward J Delp; Wayne W Campbell; Carol J Boushey; Tamara S Hannon; Nana Gletsu-Miller Journal: Contemp Clin Trials Date: 2016-12-21 Impact factor: 2.226